Chris Thompson  

Thyroid disease and Anaesthesia

Embryology

Endodermal invagination of epithelium from base of tongue, descends along Thyroglossal duct. By 10 weeks can concentrate and organify Iodine.

Anatomy

  • 15 -25 grams in weight; 2 lobes; pretracheal; isthmus at tracheal rings 2,3,4.
  • Close relationship with rec. laryngeal nerve.
  • Bloodflow very high at 5 ml/min/gm (2x kidney!) from superior (1st branch of External Carotid) and inferior thyroid arteries
  • Sup. mid. and inf. veins. Lymph follows arteries.

Function

  • Regulation of metabolic rate by T3 and T4 ex thyroid follicular cells.
  • Modification of Ca2+ metabolism by Calcinonin ex Parafollicular cells.

Iodine Metabolism

  • Dietary intake 300-500 ug/day (if < 200 μg /day → goitre); 95% absorbed, only 10-20 μg lost in faeces. Total body store 5,000-8,000 μg.
  • 80 μg/day I- actively pumped (against electrical and concentration gradients) into colloid; the same amount leaves the gland as T3 or T4.
  • Non-utilised I-, and I- from metabolism of T3 and T4, is excreted in the urine.
  • Follicle cell functions: Iodine trapping, thyroglobulin synth, T3,T4 release.
     

Thyroxine Synthesis

1) Iodine oxidation: Peroxidase on colloid membrane. Essential for uptake. Blocked by high serum Iodine levels (Wolff-Chaikoff effect), also inhibited by Perchlorate, Pertechnetate, Tc, CN-, SCN, Azides.

2) Organic Binding: MIT, DIT (Mono and di-iodotyramine). Blocked by Thiouracil, Carbimazole.

3) Oxidative coupling:

2 DIT →   T4      (3,5,3',5', tetra-iodothyramine)
DIT + MIT   →   T3     (3,5,3',tri-iodothyramine)

4) Storage: colloid contains 23% MIT, 33% DIT, 35% T4, 7% T3 bound to thyroglobulin.

5) Release: Endocytosis of colloid, destruction of thyroglobulin and release of T3 20 μg/day and T4 80 μg/day.

6) Metabolism: Hepatic deiodination, decarboxylation, conjugation.

Control of thyroxine release

HYPOTHALAMUS        

→ TRF (↑ by Cold, Emotions; ↓ by Heat, Stress)

ANTERIOR PITUITARY     (Basophil cells)

→ TSH (TSH: 211 AA's, glycoprotein, t½ 60 min) (diurnal, mw 60,000)

THYROID GLAND     (Adrenaline, vasopressin may act directly)

Effects of thyroxines

20μg/day T4 is converted to T3 in cell cytoplasm - T4 is a precursor ( ↓ in severe illness, usually associated with ↑ reverse T3, which is inactive).

Throxines act by binding to specific m-RNA causing protein synthesis with the following effects:

1) CALORIGENIC effects: ↑ 02 consumption up to 2 times; ↑ C.O., ↑ BMR, basal body temp.

2) METABOLIC effects:

↑ COH absorbtion and glucose metabolism
↑ Protein and lipid metabolism; vit. deficiency
↓ serum Cholesterol

3) CNS: Irritability, agitation, insomnia.

4) CVS: Enhanced effect of catecholamines, ↑ C.O.,↑ HR, ↑ B.P.; ↑ SVR, etc.

5) Genitourinary: ↑ Menstrual flow.

6) Essential for growth and development.

Hormone assays and blood levels

In view of high protein binding, assays of total T3 or T4 are greatly affected by pregnancy, serum protein levels, etc. High T3 strongly suggests hyperthyroidism.

Hormone

Blood level

Protein binding

T4

50-200 μg/l (70-270 nM/l)

99.97 % - TBG, Pre-albumin

T3

1-3 μg/l (2-5 nM/l)

99.5 % - TBG, Albumin

T3RU: Add blood sample to resin, then add labelled T3; measure amount of labelled T3 that binds to resin. High T3RU = few empty binding sites, suggesting hyperthyroidism or reduced protein sites. Newer tests measure T3 Plasma Uptake and are the oppposite of the old test.

FTI = T4 x T3RU(% of control) and has many subtle problems in interpretation, but looking at T4 and thinking about protein binding is the simplest early test.

Free T3 and T4: very useful. Free T4 (10-30 pM/l) may be low in the sick euthyroid patient; T3 toxicosis will show normal T4 in a toxic patient. FT3(3-12 pM/l).

I131 uptake: ↑ in thyotoxicosis. ↓ in hypothyroidism, T3 replacement, after iodine containing radiographic tests, amiodarone.

TSH:

↑ in Primary hypothyroidism or inadequate replacement
↓ in Thyroid hyperfunction or pituitary hypothyroidism

 

Anaesthesia for Hyperthyroidism

1) Assesment:

Should be clinically euthyroid, using:

  • Anti-thyroid drugs orally ( takes 6 weeks)
  • Lugols Iodine (5% KI ) for 1-2 weeks preop or Na Iodide 500 mg IV q12h
  • Beta-blockers to control sympathetic nervous system
  • Occasionally may need alpha-blockers, steroids, sedatives, lithium, etc.

Airway assessment should include:

  • ENT check of laryngeal nerves ( hoarseness, poor high pitch)
  • Asessment of postop airway adequacy; tomograms, CT, thoracic inlet XRays; exclusion of tracheomalacia
  • Selection of ETT type / size (north rae / reinforced flexible are common choices)

Hypertension, tachycardia, tremor, anxiety, fever, heat intolerance, weight loss, exophthalmos, myopathy, atrial fibrillation, all suggest poor preoperative control.

2) Premedication:

Anxiolytic, narcotic; reassurance.

3) Choice of Anaesthesia.

Usually intubation and IPPV is used to provide airway control, decreased requirements for volatile agents, still patient with little chance of coughing or straining.

Avoid agents which increase catecholamines like cyclo, ketamine. Halothane is relatively contraindicated if the surgeon uses adrenaline, and also because of tendency for postop hepatic dysfunction in thyrotoxic patients.

4) Monitoring:

Detection of disconnection or cyanosis essential and difficult as patient is completely covered in drapes. Ventilator alarm, precordial stethoscope, ETCO2, oximetry, etc should be considered.

IV, BP, ECG essential. Consider arterial line if poorly controlled.

Temperature monitoring and provision for cooling.

5) Induction:

Aim for safe induction with potentially difficult airway - consider fibreoptic, inhalational, or awake intubation in extreme cases. Test ventilate prior to nondepolarising relaxant or use sux+preoxygenation.

Choices for ETT - Latex/armoured/PVC/oral/nasal.

Control over cardiovascular refexes at all times - adequate depth of anaesthesia required.

6) Posture:

Head-down slightly, protect eyes and nerves, extend neck.

7) Extubation:

Check cord movements. IV lignocaine / Volatile agent + 100% O2.

Complications

1) Thyroid Storm

Classically 6-18 hours postoperatively. Signs:

  • Pyrexia, sweating, dehydration, hypoglycaemia, ketosis
  • Tachycardia, arrythmias, cardiac failure; occ. hypotension
  • Nausea, vomiting, diarrhoea, abdo pain
  • Restlessness, confusion, delerium.

Rx:

  • O2, cooling, IV fluids (dextrose), electrolytes, CVS monitoring + support.
  • Sedation, respiratory support as required.
  • Beta-Blockers, steroids, Na iodide (1-2 g IV/day), antithyroid drugs via NGT.

2) Nerve Damage

a) Recurrent laryngeal.

Loss causes cord adduction, sensory loss below cords.

Unilateral: Hoarseness
Bilateral: Inspiratorystridor + airway obstruction + hoarseness

b) Superior Laryngeal.

Loss causes cricothyroid paresis + sensory defect above cords.

c) Other nerves.

Phrenic / Symp chain rarely damaged.

3) Hypocalcaemia

Usually from parathyroid damage ( direct or vascular compromise); may be transient; commonly 24-48 hours postop. May cause stridor early.

4) Airway obstruction

Many possible causes, including:

  • Oedema ( laryngeal, glottic, supraglottic)
  • Haematoma causing external compression (usually acts via oedema )
  • RLN damage
  • Hypocalcaemia
  • Tracheal collapse

Manage as for any patient with compromised upper airway.

5) Others

Tracheal laceration, pneumothorax, tracheo-oesophageal fistula.

Anaesthesia for hypothyroidism

1) Assessment

Should be Euthyroid from Thyroxine replacement titrated to clinical state (100 -200 ug/day). Look for Anaemia, neuropathy, associated pituitary or adrenal hypofunction, cardiac failure.

Airway assessment as before - macroglosssia commmon.

Bradycardia, mental dullness, hypothermia, slow reflexes and TSH elevation suggest inadequate replacement. Slow drug metabolism, exaggerated responses to anaesthetic agents, decreased ventilatory responses likely.

2) Premedication

? Reduced dose.

3) Choice of anaesthetic

Intubation for same reasons as before. Avoid excessive myocardial depression.

4) Monitoring

As above. Temperature monitoring important. Use warming blanket, space blanket, humidifier. CVP if cardiac failure.

5) Posture

Care to avoid nerve compression.

Myxoedema Coma

Rx:

  • Slow warming, IV dextrose, fluids, steroids, inotropic support if required.
  • IV T3 100 ug/litre by slow infusion ( NB 40 μg/day secreted normally; give about 10 μg hourly to a max of about 80 μg - expect slow onset of effect)

 


Last updated Tuesday, December 15, 2020
Comments? please use this form.